X-Technologies, established in 1999, develops a therapeutic product - an X-ray radiation catheter for the treatment and prevention of restenosis (a significant reduction in the diameter of an artery following a percutaneous transluminal coronary angioplasty). X-Technologiesí X-ray radiation catheter is designed to radiate the angioplasty site using a millimeter scale X-ray tube delivered into the coronary artery.
In March 2003, X-Technologies was acquired by Guidant Corporation (NYSE: GDT).
    Status: Acquired  
    Fund II  

Neomedia - Keepin' it simple!